+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hospital Acquired Infection Control - Global Strategic Business Report

  • PDF Icon

    Report

  • 246 Pages
  • July 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5030036
The global market for Hospital Acquired Infection Control is estimated at US$30.1 Billion in 2023 and is projected to reach US$35.1 Billion by 2030, growing at a CAGR of 1.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Protective Barrier segment, which is expected to reach US$11.1 Billion by 2030 with a CAGR of 1.8%. The Sterilization Equipment segment is also set to grow at 2.1% CAGR over the next 8 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $8.1 Billion in 2023, and China, forecasted to grow at an impressive 2.7% CAGR to reach $6.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Hospital Acquired Infection Control Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Hospital Acquired Infection Control Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Hospital Acquired Infection Control Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Advanced Sterilization Products, Alere, Inc., Bayer AG, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 46 Featured):

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB (Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Hospital Acquired Infection Control - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Hospital Acquired Infection Control Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 8: World Recent Past, Current & Future Analysis for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Protective Barrier by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Sterilization Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Disinfectants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Hospitals & ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Ambulatory Surgery & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Nursing Homes & Maternity Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Active Players in United States
CANADA
  • Active Players in Canada
JAPAN
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Active Players in Japan
CHINA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Active Players in China
EUROPE
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Active Players in France
GERMANY
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Active Players in Germany
ITALY
  • Active Players in Italy
UNITED KINGDOM
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Active Players in United Kingdom
SPAIN
  • Active Players in Spain
RUSSIA
  • Active Players in Russia
REST OF EUROPE
  • Active Players in Rest of Europe
ASIA-PACIFIC
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • Active Players in Australia
INDIA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • Active Players in India
SOUTH KOREA
  • Active Players in South Korea
REST OF ASIA-PACIFIC
  • Active Players in Rest of Asia-Pacific
LATIN AMERICA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINA
  • Active Players in Argentina
BRAZIL
  • Active Players in Brazil
MEXICO
  • Active Players in Mexico
REST OF LATIN AMERICA
  • Active Players in Rest of Latin America
MIDDLE EAST
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRAN
  • Active Players in Iran
ISRAEL
  • Active Players in Israel
SAUDI ARABIA
  • Active Players in Saudi Arabia
UNITED ARAB EMIRATES
  • Active Players in United Arab Emirates
REST OF MIDDLE EAST
  • Active Players in Rest of Middle East
AFRICA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • Active Players in Africa
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB (Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

Table Information